Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery

被引：0
|
作者：
Dai, Cong [1 ]
Huang, Yu-hong [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, 92 Beier Rd, Shenyang 110001, Liaoning, Peoples R China
来源：
DIGESTIVE DISEASES AND SCIENCES | 2022年 / 67卷 / 04期
关键词：
Crohn's disease; Anti-TNF agents; Elective surgery; Complications; POSTOPERATIVE COMPLICATIONS; THERAPY;
D O I：
10.1007/s10620-021-06976-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [1] Risk of Infections with Anti-TNF Agents in Patients with Crohn’s Disease After Elective Surgery
    Cong Dai
    Yu-hong Huang
    Digestive Diseases and Sciences, 2022, 67 : 1421 - 1422
  • [2] Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn’s Disease After Elective Surgery: Meta-Analysis
    Jurij Hanzel
    Ahmed Almradi
    Alexandra C. Istl
    Mei Lucy Yang
    Katherine A. Fleshner
    Claire E. Parker
    Leonardo Guizzetti
    Christopher Ma
    Siddharth Singh
    Vipul Jairath
    Digestive Diseases and Sciences, 2022, 67 : 646 - 660
  • [3] Surgery for Crohn's disease and anti-TNF agents: the changing scenario
    Sorrentino, Dario
    Fogel, Sandy
    Van den Bogaerde, Johan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (08) : 689 - 700
  • [4] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [5] Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery
    Yamamoto, Takayuki
    Teixeira, Fabio Vieira
    Saad-Hossne, Rogerio
    Kotze, Paulo Gustavo
    Danese, Silvio
    CURRENT DRUG TARGETS, 2019, 20 (13) : 1339 - 1348
  • [6] Letter: should we delay surgery, or stop anti-TNF therapy prior to elective surgical procedures in Crohn's disease patients receiving anti-TNF agents?
    Yamamoto, Takayuki
    Kotze, Paulo Gustavo
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (08) : 969 - 970
  • [7] Letter: should we delay surgery, or stop anti-TNF therapy prior to elective surgical procedures in Crohn's disease patients receiving anti-TNF agents? Authors' reply
    Lin, Yang-Sheng
    Chen, Ming-Jen
    Lin, Wei-Chen
    Wang, Yuan-Hung
    Chen, Chiehfeng
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (08) : 970 - 971
  • [8] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [9] Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease
    Larsen, Michael Due
    Qvist, Niels
    Nielsen, Jan
    Kjeldsen, Jens
    Nielsen, Rasmus Gaardskaer
    Norgard, Bente Mertz
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (06) : 650 - 656
  • [10] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
12345